AGP Executive Report
Last update: 30 minutes agoEbola Response: Researchers in eastern Congo have started a WHO-backed clinical trial testing a monoclonal antibody (MBP134) and an antiviral (remdesivir) for Bundibugyo Ebola, as cases top 1,400 and deaths reach 438. Rapid Testing Race: A separate push is narrowing to five manufacturers for a rapid antigen test that could deliver results on the spot and speed up isolation in the field. Water & Space Science: A new study traces how the Congo River’s massive freshwater flow fans out into the Atlantic, using ocean modeling and observations to map the role of rotating currents in spreading the plume. Port Infrastructure: Congo Terminal completed steel pile driving for the East Mole expansion’s future quay, installing 558 piles and keeping a 2027 delivery target on track. Digital Finance: Optasia shares jumped after a trading update, with microfinancing now driving most revenue and growth expected across Ghana, Pakistan, Indonesia and the Republic of Congo.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
